Navigation Links
A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
Date:3/8/2013

California San Francisco (UCSF), a world-renowned expert in pharmacokinetics, CYP-dependent drug metabolism and P-gp dependent drug transport.

Unlike many of the novel non-monitored OACs and warfarin, tecarfarin is not metabolized by CYP enzymes or transported by P-gp in addition to not being excreted via the kidney.

"For oral anticoagulation, we believe tecarfarin if approved will be an important clinical tool in addition to warfarin and the novel non-monitored OACs. We are preparing to meet with the FDA and the EMA to propose a clinical trial design and final registration package for tecarfarin in these two regions," said Dr M. (Ken) Kengatharan ,  President & COO of Armetheon and a General Partner at Atheneos Capital. He added, "we expect to submit for marketing authorization in the US and the EU in less than 4 years. With an increasing use of CYP variant genetic testing and the recent uptick in patient self-monitoring perhaps due to reimbursement  by healthcare providers, we strongly believe the time to develop and commercialize tecarfarin is now."

About anti-coagulation therapy in special populations

Oral anticoagulants, are used to slow down or stop the formation of blood clots in the out-patient environment. Currently available anticoagulants include warfarin (Coumadin®) that inhibits vitamin K epoxide (VKOR) and the novel non-monitored OACs that directly either inhibit thrombin or Factor Xa. In patients with prosthetic heart valves, OACs are given to prevent clot formation within these valves. Patients with mechanical heart valves generally remain on warfarin sometimes in combination with aspirin while most patients with bioprosthetic valves are eventually switched to aspirin. However, experts now recommend that the novel non-monitored OACs should not to be used in these patients.

In patients, who have a genetic variant of metabolizing enzymes such as CYP2C9, anticoagul
'/>"/>

SOURCE Armetheon, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
4. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
8. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)...   NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
(Date:1/14/2014)... , Jan. 14, 2014   Evidera , a ... announced that the Center for Drug Evaluation and Research ... first draft qualification guidance document for a patient-reported outcome ... of Chronic Pulmonary Disease Tool [EXACT] for Measurement of ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... that a new market research report is available ... markets and companies http://www.reportlinker.com/p0203545/Nanobiotechnologies--applications-markets-and-companies.html ... creation and utilization of materials, devices, and systems ... scale (a nanometer is one billionth of a ...
... This Week , a leading industry publication, has honored Amedica®/US ... for Spine Care in 2010 . Amedica/US Spine, ... unique silicon nitride (SiN) ceramic technologies, received recognition in the ... Valeo® AL Lumbar Spacer and Best New Technology in ...
Cached Medicine Technology:Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 21Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week 2
(Date:4/24/2014)... Oregon State University researcher has found a relationship between ... of autism spectrum disorder in very young children. ... to show a direct relationship between motor skills and ... motor skills should be included in treatment plans for ... professor in OSU,s College of Public Health and Human ...
(Date:4/23/2014)... study by Massachusetts General Hospital (MGH) investigators may lead ... for a serious medical problem use of fecal ... by the Clostridium difficile ( C. difficile ... in the journal Clinical Infectious Diseases , the ... from donors unrelated to patients was as successful in ...
(Date:4/23/2014)... Spokane have developed a new way to detect ... the wheel. , Their recently patented technology is ... in drowsy driversand offers an affordable and more ... detection systems. , Van Dongen"Video-based systems that use ... out of its lane are cumbersome and expensive," ...
(Date:4/23/2014)... high-energy particles, simulating conditions astronauts would face on a ... slower reaction times, even when the radiation exposure is ... which affected a large subset, but far from ... to protein changes in the brain, the scientists say. ... suggest it may be possible to develop a biological ...
(Date:4/23/2014)... The internal surface area of the gastro-intestinal tract has ... square meters. Scientists at the Sahlgrenska Academy have used ... , "Actually, the inner surface of the gastro-intestinal tract ... says scientist Lars Fndriks. , The digestive tract, which ... through the intestines, has a length of about 5 ...
Breaking Medicine News(10 mins):Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:WSU innovation improves drowsy driver detection 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2
... India is closely watching the ‘Avian Flu’ that is ... formed a task force to tackle this emergency. ... and includes secretaries of health, environment, animal husbandry and ... guidelines on how to tackle the problem if it ...
... not be the only factor-probing adolescents to commit suicide.// ... for other mental health problems to prevent youth suicide. ... and distribution of mental disorders in 894 cases of ... the results of the study revealed a majority of ...
... comprises a large, heterogeneous group of rare pulmonary ... and abnormal gas exchange with considerable mortality and ... differential diagnosis includes more than 100 conditions in ... Texas and Colorado conducted a descriptive, observational study ...
... Impotence drug such as Viagra use is linked to development ... with// vision disorders have used Viagra medicines. It is found ... found to cause risk of blindness. Men most at risk ... have diabetes, heart disease, high blood pressure and high cholesterol, ...
... the first time the AID statistics from the newly formed ... cases in the state. ,Uttaranchal is a state ... lower Himalayan area with famous Hindu shrines such as Badrinath, ... the state mostly by infected drivers who are coming from ...
... disorder of impaired insulin secretion and insulin resistance, ... individuals and lifestyle management can help control diabetes; ... achieve glycemic control, a stepwise treatment approach has ... diet and exercise, and to minimize the risk ...
Cached Medicine News:Health News:Multi targeted approach required for suicide prevention in adolescents 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2Health News:Impotence drug such as Viagra may cause Vision Loss 2Health News:Glimepiride in the medical management of Type 2 diabetes 2
... for excising soft tissue more efficiently than a ... serrated edge on the straight scissor helps to ... the jaws for more efficient resection.,The curved scissors, ... the perfect tools for ACL stump removal, meniscectomies ...
... Scissor is ideal for excising soft tissue more ... the joint. The serrated edge on the straight ... hold tissue within the jaws for more efficient ... jaw curvatures, are the perfect tools for ACL ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ... style, size and angle required for large ...
Medicine Products: